hepatitisA recent study published in the Journal of the American Medical Association describes a new drug combination that may be efficacious for patients with hard-to-treat hepatitis.  The therapy includes ribavirin and an experimental drug called sofosbuvir and appears to eliminate harsh side effects by excluding Interferon. Of the 60 patients in the trial, 48 to 68 percent had the virus cleared from their bodies. Are you optimistic about these findings? Have you seen any other promising therapy for hepatitis recently?

For more information, please click here.

Image courtesy of [sscreations] / FreeDigitalPhotos.net